a trans-ancestry polygenic risk score for prostate cancer - david conti, phd
Published 2 years ago • 66 plays • Length 56:55Download video MP4
Download video MP3
Similar videos
-
1:14
polygenic risk scores for the early detection of prostate cancer
-
1:00:02
david conti, ph.d.: issues in risk prediction using polygenic risk scores across populations
-
6:05
using the polygenic risk score for targeted prostate cancer screening
-
1:20:44
burcu darst: development and application of polygenic risk scores across diverse populations
-
1:09:17
sphere seminar iv: polygenic risk scores in primary care screening
-
2:26
polygenic risk score series | discover how prss will impact clinical care
-
26:27
polygenic risk scores and disease stratification
-
24:24
education sessions: "polygenic risk score: should clinicians use it"
-
2:21
polygenic risk score series | discover key considerations for developing prs
-
1:59
polygenic risk scores (prs) for coronary disease
-
4:04
integrating polygenic risk scores with modifiable risk factors improves cancer risk score
-
53:10
mpg primer: trans-ethnic polygenic risk scores: challenges and opportunities (2020)
-
36:52
polygenic risk score analysis for alzheimer's disease risk
-
35:52
polygenic risk scores with giordano bottà
-
29:08
polygenic risk scores
-
31:14
polygenic risk scores
-
4:40
polygenic risk scores (prs) explainer collaboration video
-
3:22
clinical implementation of polygenic risk scores
-
27:27
genome-wide polygenic risk scores and pcsk9 inhibition with alirocumab
-
1:54
the correlation between composition of the gut microbiota with anti-pd-1 efficacy in cancer patients
-
1:36
a new target in t cells primes the body for immune checkpoint therapy
-
2:26
trk inhibition’s future role in precision medicine
-
31:29
a bispecific sniper™️ demo preclinical efficacy through the selective elimination of tumor tregs
-
16:24
using polygenic risk scores to predict cancer risk
-
![improve your clinical-grade treg manufacturing [webinar]](https://i.ytimg.com/vi/OVX50WhYlZY/mqdefault.jpg)
38:51
improve your clinical-grade treg manufacturing [webinar]
-
2:18
further trk inhibitor development
-
15:08
dr. cesar evaristo lecture at molecular med tri-con 2017: tumor-infiltrating immune cell populations
-
5:15
adaptive sampling reveals pathogenic repeat expansion in spinocerebellar ataxia
-
1:00
your first choice in complex biologics drug development
-
6:54
ikcs 2020: associations between serum cytokine levels and gut microbiota composition in mrcc
-
1:23
is it possible to cure genetic diseases?
-
23:05
high throughput identification of genetically distinct, target-specific antibodies
-
1:05
what are trispecific antibodies?
-
19:36
together in protein research
-
29:30
dr paul colussi - tetragenetics
-
2:15
identification of patients with luminal androgen receptor tnbc
-
33:29
prset: pathway-based polygenic risk score analyses and software
-
13:57
triumvira immunologics
-
4:10
polyplus transfection
-
58:22
panel 2 — polygenic risk scores
-
4:37
pgc: what is polygenic risk score?- till andlauer
-
19:04
the expanding dna and gene therapy market
-
5:46
clinical pharmacogenetics dataset
-
1:36
adagrasib reverses cancer multidrug resistance mediated by the transporter protein abcb1
-
4:04
polygenic risk scores - cantonese version
-
29:55
species spanning medicine
-
15:05
cti clinical trial & consulting services
-
3:27
melanoma polygenic risk scores in uk and australian cohorts, j steinberg et al
-
19:00
pluristem therapeutics
-
36:33
13: how aira matrix supports digital pathology with deep learning on demand w/ chaith kondragunta
-
19:32
immuno-oncology virtual summit 2020
-
1:11
a silver lining in biotech
-
0:41
strategic advantages of early-phase oncology clinical development across australia and the usa
-
14:27
episode 1 - retail genetics
-
2:44
immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis
-
2:04
empowering research
-
1:28
coskun lab gt: spatial multi-omics for precision medicine
-
4:31
size matters – impact of nuclear size on spatial transcriptomics’ results from human cerebral cortex
-
1:00:57
cytotoxicity of modified oligonucleotides: sequence & structure impact | dr. croft & dr. fisher
-
4:04
polygenic risk scores
-
1:33
all-trans retinoic acid boosts the efficacy of sorafenib against liver cancer
-
1:05:53
icps2018 d2 p3 andrej pavlovic
-
48:47
60: end-to-end solution for digital pathology w/ leif honda, trimetis life sciences
-
2:13
inct-biosyn: the future of synthetic biology research
-
1:33
integrinβ-1 in human disease: molecular mechanisms and therapeutic targets
-
2:55
prognostic relevance of monocytic switch and future research
-
1:01
unlocking the future: how induced pluripotent stem cells are transforming medical research
-
58:51
omics: the future of medicine and transplantation?
-
2:37
new affordable, rapid diagnostic tool to detect brain cancer
-
0:36
mastering the art of developing a successful bispecific antibody
-
54:20
club evmed: sars-cov-2 transmission bottlenecks and why we care
-
0:27
olink insight | genes to uniprot
-
3:51
this biotech analyst expects more consolidation in the space sector
-
1:04:04
antibody drug conjugates (adcs): what you need to know about this promising type of treatment
-
4:38
perception and response to cytokinins in trichoderma... - david alberto garcía estrada - la 2022
-
1:25
personalized medicine for cancer market report
-
20:02
curative biotechnology, inc $cubt is a penny stock biotech with 100x potential! 505(b)2 path!
-
49:50
spatial transcriptomics and a tumor immune-cell atlas: steps towards precision oncology
-
2:21
universal antitumore immunity augmented via albumin-flt3l
-
4:37
what are trispecific antibodies?
-
1:02:18
37: how tissue clearing - based 3d immunofluorescence allows for seeing more biology in the tissu...
-
1:31:03
patrick turley: polygenic scores i (a)
-
21:43
the epigenetic study of age acceleration in c9orf72 carriers
-
1:30
metatranscriptomics-guided metabolic reconstruction reveals insight into uncultivated microbes
-
45:59
genetic discovery to therapeutic target
-
5:16
pharmacology 1 6 genetic manipulation as sources of medications
-
0:58
childhood obesity and adult cardiovascular disease risk factors: a systematic review ... | rtcl.tv
-
1:03:04
the value of integrative medicine in oncology care d spector 20230120
-
1:07
inclinico - a platform for clinical leaders to assess trial risk and aid in portfolio triage.
-
57:56
generating a spatial atlas of the healthy and obese liver across species
-
2:07
bioidentical hormones (bhrt)
-
1:04:29
level up immune profiling of the tumor microenvironment - deep phenotyping and target discovery
-
55:26
gut motility… a poop talk with a certified gastroenterologist
-
15:44
what are polygenic risk scores and how can they be used in healthcare?
-
0:21
red